Syngenta defends U.S. operations as scrutiny of Chinese-linked agriculture intensifies

Traders Union
All News
Financial News
Syngenta defends U.S. operations

Highlights

Syngenta CEO Jeff Rowe defends the company's U.S. operations amid intensifying scrutiny of its Chinese state ties, arguing no security threat exists.
Syngenta's Q1 sales rose 2 per cent to $6.4bn and EBITDA increased 5 per cent to $1.4bn in April, with growth across all regions.
Rowe highlights that closure of the Strait of Hormuz is raising fertiliser and fuel costs for growers, and Syngenta is preparing for a future IPO with no set timing or location.

Executive response to U.S. political pressure

As reported by the Financial Times, Syngenta chief executive Jeff Rowe says the Swiss-based seeds and agrochemicals group has no harmful intent in the U.S. despite growing scrutiny of its Chinese state links. Rowe argues that agriculture and food production should sit outside broader geopolitical disputes, and says recent dialogue between U.S. President Donald Trump and China’s Xi Jinping is a positive development.

Rowe pushes back against the view that Syngenta’s ownership structure makes it a national security threat. He says the company, bought by ChemChina in 2017 and now controlled by state-owned Sinochem, is a multinational business with employees of many nationalities rather than a foreign vehicle with covert aims.

He also criticises Arkansas’s decision three years ago to force Syngenta to divest farmland because of its Chinese ties. Rowe says the move led to the closure of a local research operation, damaging jobs and weakening food security rather than delivering a clear defensive benefit.

Research network, farmer costs and listing plans

Rowe says U.S. farmers benefit from Syngenta’s global research platform and warns that breaking up international agricultural innovation networks would have significant consequences for food production. He says U.S. farmers would certainly suffer if the company’s North American business were separated from the wider group.

Syngenta reports that first-quarter sales rose 2 per cent to $6.4bn in April, while earnings before interest, tax, depreciation and amortisation increased 5 per cent to $1.4bn. Rowe says the recent momentum is not driven only by China and describes performance as strong across all regions despite difficult conditions for farmers.

He also warns that turmoil in the Middle East is adding to pressure on growers because the effective closure of the Strait of Hormuz is pushing up fertiliser and fuel costs. At the same time, Syngenta is exploring options for a future public listing after shelving a previous Shanghai plan, with Rowe saying his priority is to make the company ready for an IPO while no decision has been taken on timing or venue.

Our earlier article on Bayer’s antitrust lawsuit highlighted a new private class action accusing the company of maintaining dominance in genetically engineered corn seeds after key patents expired. The complaint focuses on alleged restrictions around the NK603 trait, continued royalty charges, and higher licensing fees—issues that add to political and regulatory pressure over competition in U.S. farm inputs and persistently high costs for growers.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.